January 7, 2013

Sanofi’s Chattem Acquires Over-the-Counter Antacid Rolaids®

Product acquisition further strengthens Consumer Healthcare Division of Sanofi US

 

Sanofi’s Chattem Acquires Over-the-Counter Antacid Rolaids®
Product acquisition further strengthens Consumer Healthcare Division of Sanofi US

Paris, France – January 7, 2013 – Sanofi (EURONEXT : SAN and NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.